In Brief: Sandoz
This article was originally published in The Tan Sheet
Executive Summary
Sandoz: Senior VP Robert Donovan leaves the firm, effective July 1. His position as head of Sandoz' U.S. consumer products business has been eliminated, Sandoz said. Chief Operating Officer Mark Pulido will oversee the OTC business "ad interim." The company would not comment on the changes except to say it remains "committed" to the U.S. consumer products business. Donovan also is stepping down as chairman of the Nonprescription Drug Manufacturers Association, which is now considering nominees for a new chairman. Donovan became head of Sandoz consumer pharmaceuticals unit in 1989 and was named a senior VP in 1994...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning